The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn's disease

被引：0
|
作者：
Kantasiripitak, W.
Mathot, R.
Oldenburg, B.
Buisson, A.
Ferrante, M.
Laharie, D.
D'Haens, C.
Vermeire, S.
Dreesen, E.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.620
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P497
引用
收藏
页码：S481 / S482
页数：3
相关论文
共 50 条
  • [41] Persistency of Infliximab Dosing in Crohn's Disease: Preliminary Results in a Chart Review
    Waters, Heidi C.
    McKenzie, R. S.
    Lunacsek, Orsolya
    Franklin, Meg
    Lennert, Barbara J.
    Piech, Catherine T.
    GASTROENTEROLOGY, 2009, 136 (05) : A176 - A176
  • [42] Review article: the efficacy of infliximab in Crohn's disease - healing of fistulae
    Present, DH
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 : 23 - 28
  • [43] Association of Infliximab trough levels and transmural healing in Crohn's disease
    Bernardo, S.
    Fernandes, S.
    Simoes, C.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Marinho, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S336 - S337
  • [44] Stability of Infliximab Dosing in Crohn's Disease: Results from a Chart Review
    Waters, Heidi
    McKenzie, Scott
    Lunacsek, Orsolya
    Franklin, Meg
    Lennert, Barbara
    Piech, Catherine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S423 - S424
  • [45] Infliximab Dosing Patterns in a Sample of Patients with Crohn's Disease: Results from a Medical Chart Review
    Tkacz, Joseph
    Jennifer, H. Lofland
    Julie, Vanderpoel
    Ruetsch, Charles
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (02): : 87 - 92
  • [46] Biomarker panel for prediction of mucosal healing in patients with Crohn's disease under infliximab therapy
    de Bruyn, M.
    Bessissow, T.
    Billiet, T.
    Cleynen, I.
    Kirkland, R.
    Liu, X.
    Hauenstein, S.
    Drake, K.
    Singh, S.
    Ferrante, M.
    Rutgeerts, P.
    Van Assche, G.
    Arijs, I.
    Opdenakker, G.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S45 - S46
  • [47] SERUM ONCOSTATIN M PREDICTS MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB
    Bertani, L.
    Antonioli, L.
    Fornili, M.
    Fornai, M.
    Tapete, G.
    Albano, E.
    Svizzero, Baiano G.
    Ceccarelli, L.
    Mumolo, M. G.
    Baglietto, L.
    Marchi, S.
    Blandizzi, C.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S125 - S126
  • [48] Infliximab is Effective to Achieve Mucosal Healing in Children With Crohn's Disease
    Kierkus, Jaroslaw
    Dadalski, Maciej
    Szymanska, Edyta
    Wegner, Agnieszka
    Oracz, Grzegorz
    Ryzko, Jozef
    GASTROENTEROLOGY, 2011, 140 (05) : S513 - S513
  • [49] Serum oncostatin M predicts mucosal healing in Crohn's disease patients treated with infliximab
    Bertani, L.
    Antonioli, L.
    Fornili, M.
    Fornai, M.
    Tapete, G.
    Albano, E.
    Svizzero, G. Baiano
    Ceccarelli, L.
    Mumolo, M. G.
    Baglietto, L.
    Marchi, S.
    Blandizzi, C.
    Costa, F.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S406 - S406
  • [50] SERUM ONCOSTATIN M PREDICTS MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB
    Bertani, Lorenzo
    Antonioli, Luca
    Fornili, Marco
    Fornai, Matteo
    Tapete, Gherardo
    Svizzero, Giovanni Baiano
    Ceccarelli, Linda
    Mumolo, Gloria M.
    Bellini, Massimo
    Baglietto, Laura
    Marchi, Santino
    Blandizzi, Corrado
    Costa, Francesco
    GASTROENTEROLOGY, 2020, 158 (06) : S1030 - S1030
12345